fluoxetine has been researched along with berberine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Dutour, R; Poirier, D | 1 |
| Caron, MG; Kiss, JP; Vizi, ES; Zsilla, G | 1 |
| Dixit, PV; Jain, DK; Jaiswal, P; Parihar, G | 1 |
| Liu, H; Sun, Y; Zhang, C; Zhu, X | 1 |
| Cao, Y; Chen, SS; Dai, GL; Ju, WZ; Li, FR; Li, Y; Liu, MC; Wang, YQ; Yang, XY | 1 |
1 review(s) available for fluoxetine and berberine
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
6 other study(ies) available for fluoxetine and berberine
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Berberine; Electric Stimulation; Female; Fluoxetine; Frontal Lobe; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Receptors, Adrenergic, alpha-2; Serotonin Plasma Membrane Transport Proteins; Symporters | 2004 |
Increased serotonergic neurotransmission is not responsible for the anticompulsive effect of berberine in a murine model of obsessive-compulsive disorder.
Topics: Aniline Compounds; Animals; Behavior, Animal; Berberine; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Injections, Intraperitoneal; Male; Mice; Motor Activity; Obsessive-Compulsive Disorder; Serotonin; Tryptophan Hydroxylase | 2012 |
Effects of berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays.
Topics: Animals; Behavior, Animal; Berberine; Bifidobacterium; Body Weight; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Gastrointestinal Microbiome; Gastrointestinal Tract; Male; Microtubule-Associated Proteins; Rats; Rats, Sprague-Dawley; Stomach; Stress, Physiological | 2017 |
[Pharmacokinetic interaction of Jiaotai Pills and Fluoxetine in rats with CUMS-induced depression].
Topics: Animals; Berberine; Chromatography, Liquid; Depression; Drugs, Chinese Herbal; Fluoxetine; Rats; Tandem Mass Spectrometry | 2022 |